MarketInOut Stock Screener Log In | Sign Up
 

Gilead Sciences Inc

NASDAQ • Healthcare • Drug Manufacturers - General • Quote as of 10/09/2026
Gilead Sciences Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization178,392 mln
Float1,238 mln
Earnings Date10/22/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-4.11
Highly reliable

1-Year Forecast

158.65
Fairly priced

Relative Strength

62 / 100
Outperforming

Debt / Equity

2.22
Very high leverage

Pre-Tax Margin

-6%
Marginally loss-making

Business Description

Gilead Sciences is an American drug company founded in 1987 and based in Foster City, California, that researches, develops, and sells treatments for serious diseases with few or no existing options. Its products cover a wide range of conditions, including HIV, hepatitis B and C, COVID-19, dangerous fungal infections, and certain cancers. The company works alongside a number of partner organizations around the world to discover and bring new therapies to patients.

Key Fundamentals

EPS-2.65
ROE-16.32
RPS24.51
ROIC26.41
ROA-5.81
Interest Cover11.95
EBITDA, mln1,782
EV / EBITDA116
EV / EBIT-216
Revenue, mln30,544
EV / Revenue6.76

Quote Details

Last 151.17
Change 4.07 (2.77%)
Open 147.23
Volume 5,332,970
Turnover 806,185,088
Average Volume 5,542,912

Financial Ratios

Pre-Tax Profit Margin-6
Leverage Ratio4.17
Current Ratio1.27
Price / Book15.76
Price / Cash Flow13.20
Price / Free Cash Flow14.40
Debt / Equity2.22
Price / Sales6.13
PEG Ratio3.11

Financial Strength

Altman Z-Score3.68
Piotroski F-Score 5 / 9
Beneish M-Score-4.11
Price to Intrinsic Value1.88
1-Year Target Price158.65
Shiller PE Ratio39.02
Short Ratio3.45
Short % of Float1.48

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.44% 90 / 100   
1 Month 4.99% 84 / 100   
2 Months 17.3% 91 / 100   
6 Months 10.1% 71 / 100   
1 Year 31.01% 85 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us